Skip to main content
logo
Cowealth Medical China Co.,Ltd. (SHA:603122)
China flag China · Delayed Price · Currency is CNY
12.14
-0.30 (-2.41%)
At close: Jun 8, 2026

Revenue by Segment

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17
In-Vitro Diagnostic Product Intensive Business
625.94M
--924.03M830.80M
In-Vitro Diagnostic Product Intensive Business Growth
-
--11.22%32.81%
Medical Product Distribution
50.54M
--110.88M70.02M
Medical Product Distribution Growth
-
--58.35%54.10%
Other Value-Added Services
1.04M
--11.68M3.04M
Other Value-Added Services Growth
-
--284.51%-66.22%
Total
677.51M
--1.05B903.85M
Total Growth
-
--15.79%32.92%

Revenue by Geography

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17
Mainland China
673.75M
----
Other
4.04M
----
China
-
1.18B1.00B--
China Growth
-
17.78%---
Overseas Areas (Including Hong Kong, Macao and Taiwan)
-
11.72M87.71M10.66M776.80K
Overseas Areas (Including Hong Kong, Macao and Taiwan) Growth
-
-86.63%722.69%1272.50%0.70%
East China
-
--736.69M611.78M
East China Growth
-
--20.42%51.57%
Northern China
-
--130.48M132.58M
Northern China Growth
-
---1.58%-0.64%
Southern China
-
--107.42M82.96M
Southern China Growth
-
--29.49%31.52%
Central China
-
--27.28M37.14M
Central China Growth
-
---26.54%-1.60%
Southwest China
-
--28.51M29.57M
Southwest China Growth
-
---3.58%-14.51%
North-East China
-
--3.47M7.15M
North-East China Growth
-
---51.43%73.28%
Northwestern China
-
--2.06M1.89M
Northwestern China Growth
-
--9.07%-27.60%
Total
677.79M
1.19B1.09B1.05B903.85M
Total Growth
-
9.37%4.05%15.79%32.92%
Source: S&P Global Market Intelligence.